| 7-Keto™ |
| This page contains additional details information, clinical trials and research data pertaining to the patented ingredient 7-Keto™, as well as its related chemical forms. You may print this page for your records if you wish. |
BackgroundIn additiona to the below information, you may also read and download the official 7-Keto broshure on additional information on how this amazing, all natural ingredient works and how you can benefit from it. 7-Keto is the registered trademark for the compound 3-Acetyl-7-oxo-dehydroepiandrosterone or 7-oxo DHEA. 7-Keto is a substance found naturally in the body. Its presence in human urine was documented in 1958. It is metabolized from the hormone DHEA, and like DHEA, it is known to decline with age. Supplementing with 7-Keto is simply putting back what time and Mother Nature has taken away. Humanetics Corporation, the developer of 7-Keto, has invested significant time and money into a methodical research program that has spanned over the past 16 years. Among other things, this research has included rigorous toxicology, pharmacokinetic and human safety trials. These studies strongly support that 7-Keto is non-toxic, cannot accumulate in the body over time, does not affect any hormone levels and is free of any serious side effects. Of even more importance, 7-Keto has been sold commercially as a dietary supplement since 1998 and, in this time, has not been linked to any serious adverse effects. Being safe is of utmost importance; however, to market a compound requires that it have a benefit to the consumer. A patent was issued in 1994 for the use of 7-Keto for effecting weight loss and preventing weight gain. The patent is built upon the discovery that 7-Keto is a potent activator of 3 important thermogenic enzymes. These enzymes are known to play an important role in helping the body convert stored fat to energy. The first of several randomized, double-blinded, placebo-controlled (“RDBPC”) weight loss clinical trials was conducted in 1999. This study indicated that 7-Keto was responsible for increasing weight loss over an eight week period by a factor of three times versus placebo. A second trial was commissioned in 2000 to confirm these results. The second trial, also RDBPC, confirmed that weight loss over a eight week period could be increased by a factor of 3 times. Importantly, each of these studies confirmed that more than 80% of the weight lost was fat. Each study controlled for diet, exercise and diuresis effects and both have been published in international peer reviewed journals. There have been three additional double-blind weight loss trials conducted on 7-Keto and formulas which contain 7-Keto. All clinical data strongly supports the efficacy of this compound and its ability to increase metabolic rate and thus accelerate weight loss. The documented science behind 7-Keto provides strong support that it is safe and effective for helping in the weight loss process. Additional Fat Loss Benefits 7-oxo-DHEA has been associated with weight loss in multiple human studies. Davidson et al. reported a study involving oral administration of 50-200 mg daily of 3-acetyl-7-oxo-DHEA (which is quickly hydrolyzed to 7-oxo-DHEA in the body) or placebo in 22 men. The body weight of the placebo group increased by 3.0 kg and the body weight of the treatment group decreased by .5 kg over a period of eight weeks, and the difference was statistically significant. This translates to a difference of one pound per week between placebo and treatment groups. However, the study was only designed to assess the safety of the substance, so it did not control for confounding variables [7]. In another study, 30 overweight people were given either placebo or 100 mg of 7-oxo-DHEA twice daily for eight weeks. They exercised three times a week for a set period of time and were instructed to eat 1800 calories per day. Both groups lost weight, but weight loss was an average of 2 lbs greater per month in the 7-oxo-DHEA group (a statistically significant difference). Body fat decreased .89% per month in the treatment group compared to .29% per month with placebo, although this was measured by calipers, as opposed to a more reliable method [15]. Other Benefits DHEA is well known to have antiglucocorticoid activity and increase the immune response. Both 7alpha-OH-DHEA and 7beta-OH-DHEA are more potent than DHEA in enhancing immune response and counteracting glucocorticoid-induced immunosuppression [11]. In some tissues, one or both have been found to counteract the effects of cortisol and the synthetic glucocorticoid dexamethasone [20-21]. Dexamethasone increases the level of 7-hydroxylating enzymes in adipose tissue, and inflammation increased metabolism of DHEA to 7alpha-DHEA in the brain of rats, indicating that metabolism of DHEA through this route may be used as a natural feedback mechanism to stimulate the immune system [21]. 7alpha-OH-DHEA increases resistance against lethal infection in animals and act as an antioxidant [2, 5]. The antiglucocorticoid action does not appear to be due to direct effects on the receptor, and is not yet well understood [11]. 7-oxo-DHEA has also been found to mitigate the immune reduction seen in mice subjected to chronic stress, with the effect being greater than that of DHEA [19]. |
| 1. Arch Biochem Biophys. 2003 Apr 15;412(2):251-8. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases? Robinzon B, Michael KK, Ripp SL, Winters SJ, Prough RA. 2. Steroids. 2004 Feb;69(2):137-44. Antioxidant effects of dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat colon, intestine and liver. Pelissier MA, Trap C, Malewiak MI, Morfin R. 3. Drug Metab Dispos. 2004 Mar;32(3):305-13. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Miller KK, Cai J, Ripp SL, Pierce WM Jr, Rushmore TH, Prough RA. 4. Biochemistry. 2002 Apr 30;41(17):5473-82. Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Gomez FE, Miyazaki M, Kim YC, Marwah P, Lardy HA, Ntambi JM, Fox BG. 5. Brain Res. 2003 Apr 18;969(1-2):117-25. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Weill-Engerer S, David JP, Sazdovitch V, Liere P, Schumacher M, Delacourte A, Baulieu EE, Akwa Y. 6. Arch Biochem Biophys. 2001 May 15;389(2):278-87. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions. Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM Jr, Prough RA. 7. Clin Invest Med. 2000 Oct;23(5):300-10. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers. Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, Lardy H. 8. Biochem Biophys Res Commun. 1999 Jan 8;254(1):120-3. An acute oral gavage study of 3beta-acetoxyandrost- 5-ene-7,17-dione (7-oxo-DHEA-acetate) in rats. Lardy H, Henwood SM, Weeks CE. 9. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 15;767(2):285-99. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. Marwah A, Marwah P, Lardy H. 10. Mol Cell Endocrinol. 2003 May 30;203(1-2):13-23. Evidence that dehydroepiandrosterone, DHEA, directly inhibits GnRH gene expression in GT1-7 hypothalamic neurons. Cui H, Lin SY, Belsham DD. 11. J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):307-16. The content of four immunomodulatory steroids and major androgens in human semen. Hampl R, Pohanka M, Hill M, Starka L. 12. Bioorg Chem. 2002 Aug;30(4):233-48. Ergosteroids VII: perchloric acid-induced transformations of 7-oxygenated steroids and their bio-analytical applications--a liquid chromatographic-mass spectrometric study. Marwah A, Marwah P, Lardy H. 13. J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):245-51. Prohormones and sport. Delbeke FT, Van Eenoo P, Van Thuyne W, Desmet N. 14. Steroids. 2000 Mar;65(3):124-9. The effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice. Shi J, Schulze S, Lardy HA. 15. J Ex Physiology online. 1999 2(4). Double-Blind Study Evaluating the Effects of Exercise Plus 3-Acetyl-7-oxo-dehydroepiandrosterone on Body Composition and Endocrine System in Overweight Adults. Colker CM, Torina GC, Swain MA, Kalman DS. 16. Arch Biochem Biophys. 1997 May 1;341(1):122-8. The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Bobyleva V, Bellei M, Kneer N, Lardy H. 17. Biochem Biophys Res Commun. 1999 Jan 8;254(1):124-6. An escalating dose oral gavage study of 3beta-acetoxyandrost-5-ene-7, 17-dione (7-oxo-DHEA-acetate) in rhesus monkeys. Henwood SM, Weeks CE, Lardy H. 18. Clin Chem Lab Med. 2003 Aug;41(8):1081-6. Relationship of dehydroepiandrosterone and its 7-hydroxylated metabolites to thyroid parameters and sex hormone-binding globulin (SHBG) in healthy subjects. Hampl R, Hill M, Bilek R, Starka L. 19. Yao Xue Xue Bao. 2003 Dec;38(12):881-4. [Effects of 7-oxo-DHEA treatment on the immunoreactivity of BALB/c mice subjected to chronic mild stress] [Article in Chinese]. Liu YY, Yang N, Kong LN, Zuo PP. 20. Physiol Res. 2000;49 Suppl 1:S107-12. 7-Hydroxydehydroepiandrosterone--a natural antiglucocorticoid and a candidate for steroid replacement therapy? Hampl R, Lapcik O, Hill M, Klak J, Kasal A, Novacek A, Sterzl I, Sterzl J, Starka L. 21. J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):133-7. 7Beta-OH-DHEA counteracts dexamethasone induced suppression of primary immune response in murine spleenocytes. Sterzl I, Hampl R, Sterzl J, Votruba J, Starka L. 22. Physiol Res. 2001;50(1):9-18. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men. Sulcova J, Hill M, Masek Z, Ceska R, Novacek A, Hampl R, Starka L. 23. Int Rev Neurobiol. 2001;46:79-95. Neurosteroid 7-hydroxylation products in the brain. Morfin R, Starka L. 24. Steroids. 2001 Jul;66(7):581-95. Ergosteroids IV: synthesis and biological activity of steroid glucuronosides, ethers, and alkylcarbonates. Marwah P, Marwah A, Kneer N, Lardy H. |
|
© 1999-2008 HFL Solutions, Inc. & Rx Research Group, Inc. All Rights Reserved
Contact Us || Site Map || Privacy Policy || Legal Notice || Disclaimer & Terms Of Use |